illuminating a new future of neurometabolic medicine for psychiatry

PHASE 1: Initial Products

Improving patients' unmet medical needs to reduce symptom chronicity, relapses & hospitalisation events

PHASE 2: Disovery Platform
‍
Scaling novel medical & healthcare research infrastructure to power biomarker platform

PHASE 3: Precision Neurometabolic Medicine

Delivering a new category of disease modifying interventions with precision medicine outcomes as the new standard of care for psychiatry

PHASE 4: Social Justice Goals

Pledging percentage of profits to be invested into increasing community mental health services in alignment with WHO and UN goals